General anaesthesia with double-lumen intubation compared to opioid-sparing strategies with laryngeal mask for thoracoscopic surgery: A randomised trial

Anaesth Crit Care Pain Med. 2022 Jun;41(3):101083. doi: 10.1016/j.accpm.2022.101083. Epub 2022 Apr 25.

Abstract

Background: General anaesthesia for thoracoscopic lung surgery can be performed with the opioid-sparing strategies without intubation and may reduce the risk of glottic injury and enhance recovery after surgery. We therefore tested the primary hypothesis that avoiding intubation reduces glottic injury.

Methods: Adults having elective thoracoscopic lung resections were randomised to: (1) intubated group: routine general anaesthesia with a double-lumen tube intubation; or, (2) non-intubated group: a bundle of opioid-sparing strategies, which included paravertebral blocks and total intravenous anaesthesia with minimal remifentanil infusion from 0.05 to 1.0 ng/mL (avoid sufentanil unless the respiratory rate exceeds 25/min or the systolic blood pressure exceeds 30% of the baseline value), no muscle relaxation, and spontaneous ventilation through a laryngeal mask. The primary outcome was glottal injury as determined by transnasal bronchoscopy one hour after removal of the laryngeal mask or double-lumen tube.

Results: Two hundred seventeen patients were assessed for the primary outcome. Sufentanil use was reduced 96% and remifentanil was reduced 40% in non-intubated opioid-sparing patients. The incidence of glottal injury was 9% (10/109) in the non-intubated vs. 37% (40/108) in the intubated patients (RR: 0.25; 95%CI: 0.13-0.47, P < 0.001). The non-intubated group also had less postoperative sore throat (8% vs. 39%; P < 0.001) and hoarseness (3% vs. 19%; P < 0.001). Postoperative pulmonary complications and lung injury biomarkers did not differ between the groups. Compared to the intubated group, the non-intubated group had less postoperative pain, faster recovery, and improved quality-of-life scores.

Conclusions: Non-intubated opioid-sparing strategies for video-assisted lung resections reduce airway injury and promote postoperative recovery.

Clinical trial number and registry url: ChiCTR1800018198 https://www.chictr.org.cn/showproj.aspx?proj=30780.

Keywords: Anaesthesia-general; Endotracheal intubation; Laryngeal mask airway; Opioid-sparing; Video-assisted thoracoscopic surgery.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Analgesics, Opioid / therapeutic use
  • Anesthesia, General / adverse effects
  • Humans
  • Intubation, Intratracheal / adverse effects
  • Laryngeal Masks* / adverse effects
  • Postoperative Complications / etiology
  • Remifentanil
  • Sufentanil
  • Thoracic Surgery, Video-Assisted

Substances

  • Analgesics, Opioid
  • Sufentanil
  • Remifentanil